Spyre Therapeutics, Inc. (SYRE)
SYRE price $93.04 +1.64 +1.79%
- Ticker
- SYRE
- Price
- $93.04
- Change
- +1.64 +1.79%
- Market cap
- $8.59B
- P/E
- -46.87
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 54
Spyre Therapeutics, Inc. is a biotechnology firm operating at the preclinical stage, dedicated to creating innovative treatments for individuals afflicted with inflammatory bowel disease (IBD). Among its pipeline candidates is SPY001, a human monoclonal immunoglobulin G1 antibody specifically engineered to target and bind with the a4ß7 integrin. This particular therapy is under development for addressing both…